BioCentury
ARTICLE | Financial News

Sherlock adds $14M to series A

April 26, 2019 5:18 AM UTC

CRISPR diagnostic company Sherlock raised an additional $14 million in its series A round Tuesday, closing the round at $31.5 million and bringing the biotech's total funding to $49 million. Northpond Ventures, Baidu Ventures and the Open Philanthropy Project led the round.

Sherlock Biosciences Inc. (Cambridge, Mass.) launched in March with $35 million in funding, including a $17.5 million non-dilutive grant from Open Philanthropy project (see "Sherlock Debuts to Develop CRISPR Diagnostics with IP from Broad, Harvard")...

BCIQ Company Profiles

Sherlock Biosciences Inc.